References

Ellansé

* Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomised, controlled clinical trial. Dermatol Surg. 2013;39 (3 Pt 1):457-63. Journal of Cosmetic Dermatology.

** Expected longevity in-vivo based on extrapolation of clinical data from –S (1 year) and –M (2 years) accepted PCL degradation behaviour.

Sinclair Network

At Sinclair we strive to provide the highest standards of training and ongoing support, working in partnership with our physician customers to deliver patients unparalleled clinical results and industry leading safety standards.

Sinclair Annual Report and Accounts 2017

Shaping the future - Sinclair Pharma PLC Annual Report and Accounts 2017. Download Now.

Sinclair Annual Report and Accounts 2016

Shaping the future. Sinclair Annual Report and Accounts 2016. Download Report

Interim Results 2018

Interim Results 2018 Sinclair Pharma plc (SPH.L), (“Sinclair”, or the “Group”, or the “Company”) the international aesthetics company, today announces its unaudited interim...

Trading Update for the 6 months to 30 June 2018

Trading Update for the 6 months to 30 June 2018 18% constant currency revenue growth ex-US. Silhouette Instalift ® £0.8 million revenue (April-June)...